Utility of Long-term Surveillance Endomyocardial Biopsy: A Multi-institutional Analysis

• Published in: The Journal of heart and lung transplantation Vol. 25; no. 12; pp. 1402 - 1409
• Main Authors: Stehlik, J., Starling, R.C., Movsesian, M.A., Fang, J.C., Brown, R.N., Hess, M.L., Lewis, N.P., Kirklin, J.K.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.12.2006; Elsevier Science
• Subjects: Adult; African Americans - statistics & numerical data; Biological and medical sciences; Biopsy; Cardiovascular System - physiopathology; Endocardium - pathology; Follow-Up Studies; Graft Rejection - epidemiology; Graft Rejection - etiology; Heart Transplantation - adverse effects; Heart Transplantation - ethnology; Humans; Immunosuppression; Incidence; Medical sciences; Middle Aged; Myocardium - pathology; Population Surveillance - methods; Postoperative Period; Registries; Risk Factors; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Surgery of the heart; Survival Analysis; Time Factors; Heart; Treatment; Surveillance; Biopsy; Analysis; Surgery; Cardiovascular disease; Institution; Long term
• ISSN: 1053-2498; 1557-3117
• DOI: 10.1016/j.healun.2006.10.003

The utility of long-term endomyocardial biopsy surveillance in heart transplant recipients has been questioned. This study was undertaken to identify risk factors for late rejection and to examine the impact of different biopsy surveillance protocols on outcomes using the registry of the Cardiac Transplant Research Database. The study group consisted of all adult patients who underwent heart transplantation at the 33 centers participating in this investigation between January 1, 1993 and January 1, 2002, survived past the second post-transplant year, and were followed-up by a defined surveillance biopsy protocol. During a follow-up that consisted of 24,137 patient-years, 1,626 late rejections occurred. Shorter time since transplant, history of rejection, younger age and African-American ethnicity of the recipient were strong risk factors for late rejection. The practice of surveillance biopsy varied among institutions. Continued surveillance increased the rate of diagnosis of late rejection (RR = 1.3, p = 0.002). There was no reduction in the incidence of hemodynamically compromising rejection and no increase in survival in patients with long-term vs intermediate-term surveillance. Short-term surveillance was associated with an increased incidence of hemodynamically compromising rejection, particularly among high-risk patients, and increased mortality in African-American patients. There are no apparent benefits from surveillance biopsy beyond 5 years post-transplant. Surveillance biopsy between 2 and 5 years post-transplant was found to reduce mortality in African-American recipients. Non–African-American recipients at high risk for late rejection will likely benefit from surveillance up to 5 years post-transplant.